Woodmont Investment Counsel LLC Sells 52 Shares of Stryker Corporation (NYSE:SYK)

Woodmont Investment Counsel LLC trimmed its holdings in shares of Stryker Corporation (NYSE:SYK) by 1.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 3,403 shares of the medical technology company’s stock after selling 52 shares during the period. Woodmont Investment Counsel LLC’s holdings in Stryker were worth $1,267,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Brighton Jones LLC raised its holdings in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares in the last quarter. Global Retirement Partners LLC raised its stake in Stryker by 14.1% during the fourth quarter. Global Retirement Partners LLC now owns 7,052 shares of the medical technology company’s stock worth $2,539,000 after acquiring an additional 869 shares in the last quarter. Private Advisor Group LLC raised its stake in Stryker by 0.4% during the fourth quarter. Private Advisor Group LLC now owns 16,027 shares of the medical technology company’s stock worth $5,771,000 after acquiring an additional 60 shares in the last quarter. Concurrent Investment Advisors LLC lifted its holdings in shares of Stryker by 13.8% during the fourth quarter. Concurrent Investment Advisors LLC now owns 8,575 shares of the medical technology company’s stock valued at $3,087,000 after acquiring an additional 1,040 shares during the period. Finally, Mattern Capital Management LLC boosted its stake in shares of Stryker by 2.0% in the 4th quarter. Mattern Capital Management LLC now owns 26,622 shares of the medical technology company’s stock valued at $9,585,000 after purchasing an additional 515 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SYK. Roth Mkm increased their target price on shares of Stryker from $405.00 to $456.00 and gave the stock a “buy” rating in a research report on Friday, May 2nd. The Goldman Sachs Group set a $422.00 price target on Stryker in a research report on Tuesday, March 4th. JMP Securities reaffirmed a “market perform” rating on shares of Stryker in a report on Monday, May 5th. Needham & Company LLC reissued a “buy” rating and issued a $442.00 price objective on shares of Stryker in a research note on Friday, March 21st. Finally, Evercore ISI lowered their price objective on shares of Stryker from $400.00 to $390.00 and set an “outperform” rating for the company in a research report on Friday, May 2nd. Four analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $427.30.

Insiders Place Their Bets

In other news, Director Ronda E. Stryker sold 200,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director now owns 3,417,326 shares in the company, valued at $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 5.90% of the company’s stock.

Stryker Price Performance

Shares of SYK opened at $375.44 on Friday. The stock has a market cap of $143.30 billion, a P/E ratio of 50.73, a price-to-earnings-growth ratio of 2.81 and a beta of 0.91. Stryker Corporation has a 1 year low of $314.93 and a 1 year high of $406.19. The stock’s 50-day moving average price is $374.95 and its two-hundred day moving average price is $375.30. The company has a current ratio of 1.64, a quick ratio of 1.00 and a debt-to-equity ratio of 0.69.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The firm had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. During the same quarter in the prior year, the firm earned $2.50 earnings per share. The business’s quarterly revenue was up 11.9% on a year-over-year basis. On average, equities analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be paid a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.89%. Stryker’s payout ratio is 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.